Epoetin Alfa 60,000 U Once Weekly Followed by 120,000 U Every 3 Weeks Increases and Maintains Hemoglobin Levels in Anemic Cancer Patients Undergoing Chemotherapy

Oncologist - United States
doi 10.1634/theoncologist.2004-0090
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Alphamed Press

Related search

Budget Impact Analysis of Darbepoetin Alfa Every 3 Weeks Versus Epoetin Alfa Every Week for Cancer Patients Receiving Chemotherapy From a Us Payer's Perspective

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Strategies for the Use of Epoetin Alfa in Breast Cancer Patients

Oncologist
Cancer ResearchMedicineOncology
1998English

Comparative Pharmacokinetics of Weekly and Every-Three-Weeks Docetaxel

Clinical Cancer Research
Cancer ResearchOncology
2004English

Once-Weekly Epoetin Beta Is Highly Effective in Treating Anaemic Patients With Lymphoproliferative Malignancy and Defective Endogenous Erythropoietin Production

British Journal of Haematology
Hematology
2004English

Weekly Versus Three Weeks Chemotherapy for Advanced Ovarian Cancer: A Meta-Analysis

Oncotarget
Oncology
2016English

Comparison of the Therapeutic Efficacy of Epoetin Beta and Epoetin Alfa in Maintenance Phase Hemodialysis Patients

Renal Failure
MedicineNephrologyCritical CareIntensive Care Medicine
2011English

Epoetin Alfa in Platinum-Treated Ovarian Cancer Patients: Results of a Multinational, Multicentre, Randomised Trial

British Journal of Cancer
Cancer ResearchOncology
2006English

Epoetin Alpha Prevents Anaemia and Reduces Transfusion Requirements in Patients Undergoing Primarily Platinum-Based Chemotherapy for Small Cell Lung Cancer

British Journal of Cancer
Cancer ResearchOncology
1999English

Bioequivalence of HX575 (Recombinant Human Epoetin Alfa) and a Comparator Epoetin Alfa After Multiple Subcutaneous Administrations

Pharmacology
MedicinePharmacology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy